Company registration number 08670889 (England and Wales)
DOVECOTE CARE LIMITED
ANNUAL REPORT AND FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2023
DOVECOTE CARE LIMITED
COMPANY INFORMATION
Director
N A Bata
Secretary
A Bata
Company number
08670889
Registered office
Ibc Suite
93 Marsh Lane
London
England
NW7 4LE
Accountants
iBC Advisory LLP
Willow Court
34 Thurmaston Lane
Leicester
LE5 0TE
Auditor
Goldwins Limited
75 Maygrove Road
West Hampstead
London
NW6 2EG
DOVECOTE CARE LIMITED
CONTENTS
Page
Strategic report
1
Director's report
2 - 3
Independent auditor's report
4 - 6
Profit and loss account
7
Group statement of comprehensive income
8
Group balance sheet
9
Company balance sheet
10
Group statement of changes in equity
11
Company statement of changes in equity
12
Group statement of cash flows
13
Company statement of cash flows
14
Notes to the financial statements
15 - 30
DOVECOTE CARE LIMITED
STRATEGIC REPORT
FOR THE YEAR ENDED 31 MARCH 2023
- 1 -

The director presents the strategic report for the year ended 31 March 2023.

Principal activities

The principal activity of the company and group continued to be the provider of residential care activities.

Review of the business

The results for the year are set out on page 7 and shows turnover for the year of £15,600,549 (2022: £10,202,982). The company's directors are satisfied with the results and financial position at the year end.

Principal risks and uncertainties

The sector remains highly competitive. Other than this, the principal risks to the company are customer demand and cost of delivering services.

Key performance indicators

The company uses a range of performance measures to monitor and manage the business effectively. The most significant of these are key performance indicators.

 

The main performance indicators for the year ended 31 March 2023 are as below:

 

 

 

 

On behalf of the board

N A Bata
Director
15 February 2024
DOVECOTE CARE LIMITED
DIRECTOR'S REPORT
FOR THE YEAR ENDED 31 MARCH 2023
- 2 -

The director presents his annual report and financial statements for the year ended 31 March 2023.

Results and dividends

The results for the year are set out on page 7.

Ordinary dividends were paid amounting to £40,000. The director does not recommend payment of a further dividend.

Director

The director who held office during the year and up to the date of signature of the financial statements was as follows:

N A Bata
Disabled persons

Applications for employment by disabled persons are always fully considered, bearing in mind the aptitudes of the applicant concerned. In the event of members of staff becoming disabled, every effort is made to ensure that their employment within the group continues and that the appropriate training is arranged. It is the policy of the group that the training, career development and promotion of disabled persons should, as far as possible, be identical to that of other employees.

Employee involvement

The group's policy is to consult and discuss with employees, through staff councils and at meetings, matters likely to affect employees' interests.

 

Information about matters of concern to employees is given through information bulletins and reports which seek to achieve a common awareness on the part of all employees of the financial and economic factors affecting the group's performance.

Statement of director's responsibilities

The director is responsible for preparing the Annual Report and the financial statements in accordance with applicable law and regulations.

 

Company law requires the director to prepare financial statements for each financial year. Under that law the director has elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the director must not approve the financial statements unless he is satisfied that they give a true and fair view of the state of affairs of the group and company, and of the profit or loss of the group for that period. In preparing these financial statements, the director is required to:

 

 

The director is responsible for keeping adequate accounting records that are sufficient to show and explain the group’s and company’s transactions and disclose with reasonable accuracy at any time the financial position of the group and company and enable them to ensure that the financial statements comply with the Companies Act 2006. He is also responsible for safeguarding the assets of the group and company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

DOVECOTE CARE LIMITED
DIRECTOR'S REPORT (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2023
- 3 -
Statement of disclosure to auditor

So far as each person who was a director at the date of approving this report is aware, there is no relevant audit information of which the auditor of the company is unaware. Additionally, the directors individually have taken all the necessary steps that they ought to have taken as directors in order to make themselves aware of all relevant audit information and to establish that the auditor of the company is aware of that information.

Medium-sized companies exemption

This report has been prepared in accordance with the provisions applicable to companies entitled to the medium-sized companies exemption.

On behalf of the board
N A Bata
Director
15 February 2024
DOVECOTE CARE LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF DOVECOTE CARE LIMITED
- 4 -
Opinion

We have audited the financial statements of DOVECOTE CARE LIMITED (the 'parent company') and its subsidiaries (the 'group') for the year ended 31 March 2023 which comprise the group profit and loss account, the group statement of comprehensive income, the group balance sheet, the company balance sheet, the group statement of changes in equity, the company statement of changes in equity, the group statement of cash flows, the company statement of cash flows and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the group and parent company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the director's use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

 

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the group's and parent company’s ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

 

Our responsibilities and the responsibilities of the director with respect to going concern are described in the relevant sections of this report.

Other information

The other information comprises the information included in the annual report other than the financial statements and our auditor's report thereon. The director is responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

 

We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of our audit:

DOVECOTE CARE LIMITED
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBERS OF DOVECOTE CARE LIMITED
- 5 -
Matters on which we are required to report by exception

In the light of the knowledge and understanding of the group and the parent company and their environment obtained in the course of the audit, we have not identified material misstatements in the strategic report or the director's report.

 

We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:

Responsibilities of director

As explained more fully in the director's responsibilities statement, the director is responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the director determines is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the director is responsible for assessing the parent company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the director either intends to liquidate the parent company or to cease operations, or has no realistic alternative but to do so.

Auditor's responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud are set out below.

In identifying and assessing risks of material misstatement in respect of irregularities, including fraud and non-compliance with laws and regulations, our procedures included the following:

 

 

Because of the inherent limitations of an audit, there is a risk that we will not detect all irregularities, including those leading to a material misstatement in the financial statements or non-compliance with regulation. The risk is also greater regarding irregularities occurring due to fraud rather than error, as fraud involves intentional concealment, forgery, collusion, omission or misrepresentation.

A further description of our responsibilities is available on the Financial Reporting Council’s website at: https://www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.

 

DOVECOTE CARE LIMITED
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBERS OF DOVECOTE CARE LIMITED
- 6 -

Use of our report

This report is made solely to the company’s members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company’s members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company’s members as a body, for our audit work, for this report, or for the opinions we have formed.

Anthony Epton (Senior Statutory Auditor)
For and on behalf of Goldwins Limited
15 February 2024
Chartered Accountants
Statutory Auditor
75 Maygrove Road
West Hampstead
London
NW6 2EG
DOVECOTE CARE LIMITED
GROUP PROFIT AND LOSS ACCOUNT
FOR THE YEAR ENDED 31 MARCH 2023
- 7 -
2023
2022
Notes
£
£
Turnover
3
15,600,548
10,202,982
Cost of sales
(11,319,009)
(6,527,296)
Gross profit
4,281,539
3,675,686
Distribution costs
(239,043)
(138,932)
Administrative expenses
(2,224,554)
(1,662,388)
Other operating income
16,535
224,077
Operating profit
4
1,834,477
2,098,443
Interest receivable and similar income
7
5,146
21
Interest payable and similar expenses
8
(365,383)
(32,289)
Amounts written off investments
9
25,000
-
Profit before taxation
1,499,240
2,066,175
Tax on profit
10
(393,246)
(144,556)
Profit for the financial year
1,105,994
1,921,619
Profit for the financial year is attributable to:
- Owners of the parent company
1,187,739
1,974,091
- Non-controlling interests
(81,745)
(52,472)
1,105,994
1,921,619
DOVECOTE CARE LIMITED
GROUP STATEMENT OF COMPREHENSIVE INCOME
FOR THE YEAR ENDED 31 MARCH 2023
- 8 -
2023
2022
£
£
Profit for the year
1,105,994
1,921,619
Other comprehensive income
-
-
Total comprehensive income for the year
1,105,994
1,921,619
Total comprehensive income for the year is attributable to:
- Owners of the parent company
1,187,739
1,974,091
- Non-controlling interests
(81,745)
(52,472)
1,105,994
1,921,619
DOVECOTE CARE LIMITED
GROUP BALANCE SHEET
AS AT 31 MARCH 2023
31 March 2023
- 9 -
2023
2022
Notes
£
£
£
£
Fixed assets
Intangible assets
12
1
1
Tangible assets
13
7,279,542
6,549,346
7,279,543
6,549,347
Current assets
Debtors
15
6,199,128
7,009,803
Cash at bank and in hand
2,019,381
2,378,125
8,218,509
9,387,928
Creditors: amounts falling due within one year
16
(6,800,314)
(2,984,512)
Net current assets
1,418,195
6,403,416
Total assets less current liabilities
8,697,738
12,952,763
Creditors: amounts falling due after more than one year
17
(45,058)
(5,537,335)
Provisions for liabilities
Deferred tax liability
19
321,943
82,073
(321,943)
(82,073)
Net assets
8,330,737
7,333,355
Capital and reserves
Called up share capital
21
1
1
Revaluation reserve
600,000
600,000
Profit and loss reserves
7,809,529
6,799,014
Equity attributable to owners of the parent company
8,409,530
7,399,015
Non-controlling interests
(78,793)
(65,660)
8,330,737
7,333,355

These financial statements have been prepared in accordance with the provisions relating to medium-sized groups.

The financial statements were approved and signed by the director and authorised for issue on 15 February 2024
15 February 2024
N A Bata
Director
Company registration number 08670889 (England and Wales)
DOVECOTE CARE LIMITED
COMPANY BALANCE SHEET
AS AT 31 MARCH 2023
31 March 2023
- 10 -
2023
2022
Notes
£
£
£
£
Fixed assets
Tangible assets
13
2,595,281
3,645,281
Investments
14
346,946
346,946
2,942,227
3,992,227
Current assets
Debtors
15
1,233,645
4,383,544
Cash at bank and in hand
22,673
748,491
1,256,318
5,132,035
Creditors: amounts falling due within one year
16
(4,155,127)
(2,592,193)
Net current (liabilities)/assets
(2,898,809)
2,539,842
Total assets less current liabilities
43,418
6,532,069
Creditors: amounts falling due after more than one year
17
-
(5,472,725)
Net assets
43,418
1,059,344
Capital and reserves
Called up share capital
21
1
1
Revaluation reserve
600,000
600,000
Profit and loss reserves
(556,583)
459,343
Total equity
43,418
1,059,344

As permitted by s408 Companies Act 2006, the company has not presented its own profit and loss account and related notes. The company’s loss for the year was £975,926 (2022 - £94,811 profit).

The financial statements were approved and signed by the director and authorised for issue on 15 February 2024
15 February 2024
N A Bata
Director
Company registration number 08670889 (England and Wales)
DOVECOTE CARE LIMITED
GROUP STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 MARCH 2023
- 11 -
Share capital
Revaluation reserve
Profit and loss reserves
Total controlling interest
Non-controlling interest
Total
Notes
£
£
£
£
£
£
Balance at 1 April 2021
1
600,000
4,961,523
5,561,524
(41,988)
5,519,536
Year ended 31 March 2022:
Profit and total comprehensive income
-
-
1,974,091
1,974,091
(52,472)
1,921,619
Dividends
11
-
-
(136,600)
(136,600)
28,800
(107,800)
Balance at 31 March 2022
1
600,000
6,799,014
7,399,015
(65,660)
7,333,355
Year ended 31 March 2023:
Profit and total comprehensive income
-
-
1,187,739
1,187,739
(81,745)
1,105,994
Dividends
11
-
-
(177,224)
(177,224)
68,612
(108,612)
Balance at 31 March 2023
1
600,000
7,809,529
8,409,530
(78,793)
8,330,737
DOVECOTE CARE LIMITED
COMPANY STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 MARCH 2023
- 12 -
Share capital
Revaluation reserve
Profit and loss reserves
Total
Notes
£
£
£
£
Balance at 1 April 2021
1
600,000
443,532
1,043,533
Year ended 31 March 2022:
Profit and total comprehensive income for the year
-
-
94,811
94,811
Dividends
11
-
-
(79,000)
(79,000)
Balance at 31 March 2022
1
600,000
459,343
1,059,344
Year ended 31 March 2023:
Profit and total comprehensive income
-
-
(975,926)
(975,926)
Dividends
11
-
-
(40,000)
(40,000)
Balance at 31 March 2023
1
600,000
(556,583)
43,418
DOVECOTE CARE LIMITED
GROUP STATEMENT OF CASH FLOWS
FOR THE YEAR ENDED 31 MARCH 2023
- 13 -
2023
2022
Notes
£
£
£
£
Cash flows from operating activities
Cash generated from operations
23
1,321,315
1,438,333
Interest paid
(365,383)
(32,289)
Income taxes paid
(187,893)
(130,615)
Net cash inflow from operating activities
768,039
1,275,429
Investing activities
Purchase of tangible fixed assets
(2,004,012)
(2,733,887)
Proceeds from disposal of tangible fixed assets
1,063,499
2,369,777
Proceeds from disposal of investments
25,000
(100)
Repayment of loans
(107,574)
-
Interest received
5,146
21
Net cash used in investing activities
(1,017,941)
(364,189)
Financing activities
Proceeds from new bank loans
-
42,951
Repayment of bank loans
(230)
(660,834)
Dividends paid to equity shareholders
(177,224)
(136,600)
Dividends paid to non-controlling interests
68,612
28,800
Net cash used in financing activities
(108,842)
(725,683)
Net (decrease)/increase in cash and cash equivalents
(358,744)
185,557
Cash and cash equivalents at beginning of year
2,378,125
2,192,568
Cash and cash equivalents at end of year
2,019,381
2,378,125
DOVECOTE CARE LIMITED
COMPANY STATEMENT OF CASH FLOWS
FOR THE YEAR ENDED 31 MARCH 2023
- 14 -
2023
2022
Notes
£
£
£
£
Cash flows from operating activities
Cash (absorbed by)/generated from operations
24
(1,570,036)
2,362,997
Interest paid
(300,481)
(14,412)
Income taxes paid
-
0
(848)
Net cash (outflow)/inflow from operating activities
(1,870,517)
2,347,737
Investing activities
Purchase of tangible fixed assets
-
0
(2,306,679)
Proceeds from disposal of tangible fixed assets
1,050,000
-
0
Proceeds from disposal of investments
25,000
(100)
Repayment of loans
(107,574)
-
0
Dividends received
217,273
91,200
Net cash generated from/(used in) investing activities
1,184,699
(2,215,579)
Financing activities
Dividends paid to equity shareholders
(40,000)
(79,000)
Net cash used in financing activities
(40,000)
(79,000)
Net (decrease)/increase in cash and cash equivalents
(725,818)
53,158
Cash and cash equivalents at beginning of year
748,491
695,333
Cash and cash equivalents at end of year
22,673
748,491
DOVECOTE CARE LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2023
- 15 -
1
Accounting policies
Company information

DOVECOTE CARE LIMITED (“the company”) is a private limited company domiciled and incorporated in England and Wales. The registered office is Ibc Suite, 93 Marsh Lane, London, England, NW7 4LE.

 

The group consists of DOVECOTE CARE LIMITED and all of its subsidiaries.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, [modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value]. The principal accounting policies adopted are set out below.

1.2
Business combinations

In the parent company financial statements, the cost of a business combination is the fair value at the acquisition date of the assets given, equity instruments issued and liabilities incurred or assumed, plus costs directly attributable to the business combination. The excess of the cost of a business combination over the fair value of the identifiable assets, liabilities and contingent liabilities acquired is recognised as goodwill. The cost of the combination includes the estimated amount of contingent consideration that is probable and can be measured reliably, and is adjusted for changes in contingent consideration after the acquisition date. Provisional fair values recognised for business combinations in previous periods are adjusted retrospectively for final fair values determined in the 12 months following the acquisition date. Investments in subsidiaries, joint ventures and associates are accounted for at cost less impairment.

 

Deferred tax is recognised on differences between the value of assets (other than goodwill) and liabilities recognised in a business combination accounted for using the purchase method and the amounts that can be deducted or assessed for tax, considering the manner in which the carrying amount of the asset or liability is expected to be recovered or settled. The deferred tax recognised is adjusted against goodwill or negative goodwill.

1.3
Basis of consolidation

The consolidated group financial statements consist of the financial statements of the parent company DOVECOTE CARE LIMITED together with all entities controlled by the parent company (its subsidiaries) and the group’s share of its interests in joint ventures and associates.

 

All financial statements are made up to 31 March 2023. Where necessary, adjustments are made to the financial statements of subsidiaries to bring the accounting policies used into line with those used by other members of the group.

 

All intra-group transactions, balances and unrealised gains on transactions between group companies are eliminated on consolidation. Unrealised losses are also eliminated unless the transaction provides evidence of an impairment of the asset transferred.

Subsidiaries are consolidated in the group’s financial statements from the date that control commences until the date that control ceases.

DOVECOTE CARE LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2023
1
Accounting policies
(Continued)
- 16 -

Entities in which the group holds an interest and which are jointly controlled by the group and one or more other venturers under a contractual arrangement are treated as joint ventures. Entities other than subsidiary undertakings or joint ventures, in which the group has a participating interest and over whose operating and financial policies the group exercises a significant influence, are treated as associates.

Investments in joint ventures and associates are carried in the group balance sheet at cost plus post-acquisition changes in the group’s share of the net assets of the entity, less any impairment in value. The carrying values of investments in joint ventures and associates include acquired goodwill.

 

If the group’s share of losses in a joint venture or associate equals or exceeds its investment in the joint venture or associate, the group does not recognise further losses unless it has incurred obligations to do so or has made payments on behalf of the joint venture or associate.

 

Unrealised gains arising from transactions with joint ventures and associates are eliminated to the extent of the group’s interest in the entity.

1.4
Going concern

At the time of approving the financial statements, the director has a reasonable expectation that the group has adequate resources to continue in operational existence for the foreseeable future. Thus the director continues to adopt the going concern basis of accounting in preparing the financial statements.

1.5
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

 

When cash inflows are deferred and represent a financing arrangement, the fair value of the consideration is the present value of the future receipts. The difference between the fair value of the consideration and the nominal amount received is recognised as interest income.

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.

1.6
Intangible fixed assets other than goodwill

Intangible assets acquired separately from a business are recognised at cost and are subsequently measured at cost less accumulated amortisation and accumulated impairment losses.

 

Intangible assets acquired on business combinations are recognised separately from goodwill at the acquisition date where it is probable that the expected future economic benefits that are attributable to the asset will flow to the entity and the fair value of the asset can be measured reliably; the intangible asset arises from contractual or other legal rights; and the intangible asset is separable from the entity.

Amortisation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Intangible Assets
Nil
1.7
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

DOVECOTE CARE LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2023
1
Accounting policies
(Continued)
- 17 -

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Freehold land and buildings
Nil
Leasehold land and buildings
10% Straight Line
Leasehold improvements
10% Straight Line
Plant and equipment
20% Reducing Balance
Fixtures and fittings
20% Reducing Balance
Motor vehicles
25% Reducing Balance

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is recognised in the profit and loss account.

1.8
Fixed asset investments

Equity investments are measured at fair value through profit or loss, except for those equity investments that are not publicly traded and whose fair value cannot otherwise be measured reliably, which are recognised at cost less impairment until a reliable measure of fair value becomes available.

 

In the parent company financial statements, investments in subsidiaries, associates and jointly controlled entities are initially measured at cost and subsequently measured at cost less any accumulated impairment losses.

A subsidiary is an entity controlled by the group. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.

An associate is an entity, being neither a subsidiary nor a joint venture, in which the company holds a long-term interest and where the company has significant influence. The group considers that it has significant influence where it has the power to participate in the financial and operating decisions of the associate.

 

Investments in associates are initially recognised at the transaction price (including transaction costs) and are subsequently adjusted to reflect the group’s share of the profit or loss, other comprehensive income and equity of the associate using the equity method. Any difference between the cost of acquisition and the share of the fair value of the net identifiable assets of the associate on acquisition is recognised as goodwill. Any unamortised balance of goodwill is included in the carrying value of the investment in associates.

 

Losses in excess of the carrying amount of an investment in an associate are recorded as a provision only when the company has incurred legal or constructive obligations or has made payments on behalf of the associate.

 

In the parent company financial statements, investments in associates are accounted for at cost less impairment.

Entities in which the group has a long term interest and shares control under a contractual arrangement are classified as jointly controlled entities.

DOVECOTE CARE LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2023
1
Accounting policies
(Continued)
- 18 -
1.9
Impairment of fixed assets

At each reporting period end date, the group reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

 

The carrying amount of the investments accounted for using the equity method is tested for impairment as a single asset. Any goodwill included in the carrying amount of the investment is not tested separately for impairment.

Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

 

If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.

1.10
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.11
Financial instruments

The group has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the group's balance sheet when the group becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset and the net amounts presented in the financial statements when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

DOVECOTE CARE LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2023
1
Accounting policies
(Continued)
- 19 -
Other financial assets

Other financial assets, including investments in equity instruments which are not subsidiaries, associates or joint ventures, are initially measured at fair value, which is normally the transaction price. Such assets are subsequently carried at fair value and the changes in fair value are recognised in profit or loss, except that investments in equity instruments that are not publicly traded and whose fair values cannot be measured reliably are measured at cost less impairment.

Impairment of financial assets

Financial assets, other than those held at fair value through profit and loss, are assessed for indicators of impairment at each reporting end date.

 

Financial assets are impaired where there is objective evidence that, as a result of one or more events that occurred after the initial recognition of the financial asset, the estimated future cash flows have been affected. If an asset is impaired, the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in profit or loss.

 

If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been, had the impairment not previously been recognised. The impairment reversal is recognised in profit or loss.

Derecognition of financial assets

Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the group transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the group after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

DOVECOTE CARE LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2023
1
Accounting policies
(Continued)
- 20 -
Other financial liabilities

Derivatives, including interest rate swaps and forward foreign exchange contracts, are not basic financial instruments. Derivatives are initially recognised at fair value on the date a derivative contract is entered into and are subsequently re-measured at their fair value. Changes in the fair value of derivatives are recognised in profit or loss in finance costs or finance income as appropriate, unless hedge accounting is applied and the hedge is a cash flow hedge.

 

Debt instruments that do not meet the conditions in FRS 102 paragraph 11.9 are subsequently measured at fair value through profit or loss. Debt instruments may be designated as being measured at fair value through profit or loss to eliminate or reduce an accounting mismatch or if the instruments are measured and their performance evaluated on a fair value basis in accordance with a documented risk management or investment strategy.

Derecognition of financial liabilities

Financial liabilities are derecognised when the group's contractual obligations expire or are discharged or cancelled.

1.12
Equity instruments

Equity instruments issued by the group are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the group.

1.13
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The group’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset if, and only if, there is a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

DOVECOTE CARE LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2023
1
Accounting policies
(Continued)
- 21 -
1.14
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

 

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.15
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.16
Leases

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leased asset are consumed.

Rental income from operating leases is recognised on a straight line basis over the term of the relevant lease. Initial direct costs incurred in negotiating and arranging an operating lease are added to the carrying amount of the leased asset and recognised on a straight line basis over the lease term.

1.17
Government grants

Government grants are recognised at the fair value of the asset received or receivable when there is reasonable assurance that the grant conditions will be met and the grants will be received.

 

A grant that specifies performance conditions is recognised in income when the performance conditions are met. Where a grant does not specify performance conditions it is recognised in income when the proceeds are received or receivable. A grant received before the recognition criteria are satisfied is recognised as a liability.

2
Judgements and key sources of estimation uncertainty

In the application of the group’s accounting policies, the director is required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

3
Turnover and other revenue
2023
2022
£
£
Turnover analysed by class of business
Sales
15,600,549
10,202,982
Analysis per statutory database
15,600,549
10,202,982
Statutory database analysis does not agree to the trial balance by:
1
-
DOVECOTE CARE LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2023
3
Turnover and other revenue
(Continued)
- 22 -
2023
2022
£
£
Turnover analysed by geographical market
United Kingdom
15,600,549
10,202,982
Analysis per statutory database
15,600,549
10,202,982
Statutory database analysis does not agree to the trial balance by:
1
-
2023
2022
£
£
Other revenue
Interest income
5,146
21
Grants received
16,535
199,577
4
Operating profit
2023
2022
£
£
Operating profit for the year is stated after charging/(crediting):
Government grants
(16,535)
(199,577)
Depreciation of owned tangible fixed assets
211,202
98,509
Profit on disposal of tangible fixed assets
(885)
(1,552)
Operating lease charges
9,464
215
5
Auditor's remuneration
2023
2022
Fees payable to the company's auditor and associates:
£
£
For audit services
Audit of the financial statements of the group and company
18,000
-
6
Employees

The average monthly number of persons (including directors) employed by the group and company during the year was:

Group
Company
2023
2022
2023
2022
Number
Number
Number
Number
504
334
43
-
0
DOVECOTE CARE LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2023
6
Employees
(Continued)
- 23 -

Their aggregate remuneration comprised:

Group
Company
2023
2022
2023
2022
£
£
£
£
Wages and salaries
10,295,308
5,922,219
866,156
-
0
Social security costs
610,755
323,564
87,575
-
Pension costs
111,249
71,552
14,727
-
0
11,017,312
6,317,335
968,458
-
0
7
Interest receivable and similar income
2023
2022
£
£
Interest income
Other interest income
5,146
21
8
Interest payable and similar expenses
2023
2022
£
£
Interest on financial liabilities measured at amortised cost:
Interest on bank overdrafts and loans
361,658
32,289
Other interest on financial liabilities
3,725
-
365,383
32,289
9
Amounts written off investments
2023
2022
£
£
Gain on disposal of financial assets held at cost
25,000
-
10
Taxation
2023
2022
£
£
Current tax
UK corporation tax on profits for the current period
155,206
106,120
Deferred tax
Origination and reversal of timing differences
238,040
38,436
Total tax charge
393,246
144,556
DOVECOTE CARE LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2023
- 24 -
11
Dividends
2023
2022
Recognised as distributions to equity holders:
£
£
Final paid
40,000
79,000
12
Intangible fixed assets
Group
Intangible Assets
£
Cost
At 1 April 2022 and 31 March 2023
1
Amortisation and impairment
At 1 April 2022 and 31 March 2023
-
0
Carrying amount
At 31 March 2023
1
At 31 March 2022
1
The company had no intangible fixed assets at 31 March 2023 or 31 March 2022.
DOVECOTE CARE LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2023
- 25 -
13
Tangible fixed assets
Group
Freehold land and buildings
Leasehold land and buildings
Leasehold improvements
Plant and equipment
Fixtures and fittings
Motor vehicles
Total
£
£
£
£
£
£
£
Cost
At 1 April 2022
6,005,676
9,694
112,334
111,670
323,934
382,128
6,945,436
Additions
510,210
-
0
173,262
-
0
859,026
461,514
2,004,012
Disposals
(1,050,000)
-
0
-
0
-
0
-
0
(13,900)
(1,063,900)
At 31 March 2023
5,465,886
9,694
285,596
111,670
1,182,960
829,742
7,885,548
Depreciation and impairment
At 1 April 2022
969
5,817
15,428
45,514
199,306
129,056
396,090
Depreciation charged in the year
970
-
0
16,113
16,875
76,379
100,865
211,202
Eliminated in respect of disposals
-
0
-
0
-
0
-
0
-
0
(1,286)
(1,286)
At 31 March 2023
1,939
5,817
31,541
62,389
275,685
228,635
606,006
Carrying amount
At 31 March 2023
5,463,947
3,877
254,055
49,281
907,275
601,107
7,279,542
At 31 March 2022
6,004,707
3,877
96,906
66,156
124,628
253,072
6,549,346
DOVECOTE CARE LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2023
- 26 -
Company
Freehold land and buildings
£
Cost
At 1 April 2022
3,645,281
Disposals
(1,050,000)
At 31 March 2023
2,595,281
Depreciation and impairment
At 1 April 2022 and 31 March 2023
-
0
Carrying amount
At 31 March 2023
2,595,281
At 31 March 2022
3,645,281
14
Fixed asset investments
Group
Company
2023
2022
2023
2022
£
£
£
£
Unlisted investments
-
0
-
0
346,946
346,946
Movements in fixed asset investments
Company
Investments
£
Cost or valuation
At 1 April 2022 and 31 March 2023
346,946
Carrying amount
At 31 March 2023
346,946
At 31 March 2022
346,946
15
Debtors
Group
Company
2023
2022
2023
2022
Amounts falling due within one year:
£
£
£
£
Trade debtors
1,071,172
489,619
-
0
-
0
Other debtors
4,891,999
6,354,247
1,233,645
4,383,544
Prepayments and accrued income
235,957
165,937
-
0
-
0
6,199,128
7,009,803
1,233,645
4,383,544
DOVECOTE CARE LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2023
- 27 -
16
Creditors: amounts falling due within one year
Group
Company
2023
2022
2023
2022
Notes
£
£
£
£
Bank loans
18
91,052
71,730
-
0
-
0
Trade creditors
593,103
302,453
-
0
-
0
Corporation tax payable
16,407
50,924
-
0
-
0
Other taxation and social security
645,012
667,535
35,063
846
Other creditors
5,273,736
1,717,058
4,120,064
2,591,347
Accruals and deferred income
181,004
174,812
-
0
-
0
6,800,314
2,984,512
4,155,127
2,592,193
17
Creditors: amounts falling due after more than one year
Group
Company
2023
2022
2023
2022
Notes
£
£
£
£
Bank loans and overdrafts
18
45,058
64,610
-
0
-
0
Other creditors
-
0
5,472,725
-
0
5,472,725
45,058
5,537,335
-
5,472,725
18
Loans and overdrafts
Group
Company
2023
2022
2023
2022
£
£
£
£
Bank loans
136,110
136,340
-
0
-
0
Payable within one year
91,052
71,730
-
0
-
0
Payable after one year
45,058
64,610
-
0
-
0
19
Deferred taxation

The following are the major deferred tax liabilities and assets recognised by the group and company, and movements thereon:

Liabilities
Liabilities
2023
2022
Group
£
£
Other timing difference
321,943
82,073
DOVECOTE CARE LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2023
19
Deferred taxation
(Continued)
- 28 -
Liabilities
Liabilities
2023
2022
£
£
Company
-
-
20
Retirement benefit schemes
2023
2022
Defined contribution schemes
£
£
Charge to profit or loss in respect of defined contribution schemes
111,249
71,552

A defined contribution pension scheme is operated for all qualifying employees. The assets of the scheme are held separately from those of the group in an independently administered fund.

21
Share capital
Group and company
2023
2022
2023
2022
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary share of £1 each
1
1
1
1
22
Related party transactions
Transactions with related parties

Director' Loan Account - these loans are free of interest and repayable on demand. The amount is included within other debtors/creditors.

 

Amount due from the related party 2023: £107,574 (2022:£350,042).

 

The overdrawn director loan account has been repaid within 9 months.

 

Included in other debtors is an amount of £995,310 (2022: £4,379,356) due to companies connected by virtue of common directorship and shareholding.

 

Included in other creditors is an amount of £1,886,350 (2022: £217,000) due from companies connected by virtue of common directorship and shareholding.

DOVECOTE CARE LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2023
- 29 -
23
Cash generated from group operations
2023
2022
£
£
Profit for the year after tax
1,105,994
1,921,619
Adjustments for:
Taxation charged
393,246
144,556
Finance costs
365,383
32,289
Investment income
(5,146)
(21)
Gain on disposal of tangible fixed assets
(885)
(1,552)
Depreciation and impairment of tangible fixed assets
211,202
98,509
Other gains and losses
(25,000)
-
Movements in working capital:
Decrease in debtors
918,249
150,813
Decrease in creditors
(1,641,728)
(907,880)
Cash generated from operations
1,321,315
1,438,333
24
Cash (absorbed by)/generated from operations - company
2023
2022
£
£
(Loss)/profit for the year after tax
(975,926)
94,811
Adjustments for:
Taxation charged
-
0
847
Finance costs
300,481
14,412
Investment income
(217,273)
(91,200)
Other gains and losses
(25,000)
-
Movements in working capital:
Decrease in debtors
3,257,473
20,907
(Decrease)/increase in creditors
(3,909,791)
2,323,220
Cash (absorbed by)/generated from operations
(1,570,036)
2,362,997
25
Analysis of changes in net funds - group
1 April 2022
Cash flows
31 March 2023
£
£
£
Cash at bank and in hand
2,378,125
(358,744)
2,019,381
Borrowings excluding overdrafts
(136,340)
230
(136,110)
2,241,785
(358,514)
1,883,271
DOVECOTE CARE LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2023
- 30 -
26
Analysis of changes in net funds - company
1 April 2022
Cash flows
31 March 2023
£
£
£
Cash at bank and in hand
748,491
(725,818)
22,673
2023-03-312022-04-01falseCCH SoftwareCCH Accounts Production 2023.300N A BataA Batafalse08670889bus:Consolidated2022-04-012023-03-31086708892022-04-012023-03-3108670889bus:Director12022-04-012023-03-3108670889bus:CompanySecretary12022-04-012023-03-3108670889bus:RegisteredOffice2022-04-012023-03-31086708892023-03-3108670889bus:Consolidated2021-04-012022-03-31086708892021-04-012022-03-3108670889bus:Consolidated2023-03-3108670889core:OtherResidualIntangibleAssetsbus:Consolidated2023-03-3108670889core:OtherResidualIntangibleAssetsbus:Consolidated2022-03-3108670889core:Non-standardIntangibleAssetClass1ComponentIntangibleAssetsOtherThanGoodwillbus:Consolidated2023-03-3108670889core:Non-standardIntangibleAssetClass1ComponentIntangibleAssetsOtherThanGoodwillbus:Consolidated2022-03-3108670889bus:Consolidated2022-03-31086708892022-03-3108670889core:LandBuildingscore:OwnedOrFreeholdAssetsbus:Consolidated2023-03-3108670889core:LandBuildingscore:LeasedAssetsHeldAsLesseebus:Consolidated2023-03-3108670889core:LeaseholdImprovementsbus:Consolidated2023-03-3108670889core:PlantMachinerybus:Consolidated2023-03-3108670889core:FurnitureFittingsbus:Consolidated2023-03-3108670889core:MotorVehiclesbus:Consolidated2023-03-3108670889core:LandBuildingscore:OwnedOrFreeholdAssetsbus:Consolidated2022-03-3108670889core:LandBuildingscore:LeasedAssetsHeldAsLesseebus:Consolidated2022-03-3108670889core:LeaseholdImprovementsbus:Consolidated2022-03-3108670889core:PlantMachinerybus:Consolidated2022-03-3108670889core:FurnitureFittingsbus:Consolidated2022-03-3108670889core:MotorVehiclesbus:Consolidated2022-03-3108670889core:LandBuildingscore:OwnedOrFreeholdAssets2023-03-3108670889core:LandBuildingscore:OwnedOrFreeholdAssets2022-03-3108670889core:ShareCapitalbus:Consolidated2023-03-3108670889core:ShareCapitalbus:Consolidated2022-03-3108670889core:RevaluationReservebus:Consolidated2023-03-3108670889core:RevaluationReservebus:Consolidated2022-03-3108670889core:ShareCapital2023-03-3108670889core:ShareCapital2022-03-3108670889core:RevaluationReserve2023-03-3108670889core:RevaluationReserve2022-03-3108670889core:RetainedEarningsAccumulatedLosses2023-03-3108670889core:ShareCapitalbus:Consolidated2021-03-3108670889core:SharePremiumbus:Consolidated2021-03-3108670889core:RetainedEarningsAccumulatedLossesbus:Consolidated2021-03-3108670889core:RetainedEarningsAccumulatedLossesbus:Consolidated2022-03-3108670889core:Non-controllingInterestsbus:Consolidated2022-03-3108670889core:RetainedEarningsAccumulatedLossesbus:Consolidated2023-03-3108670889core:Non-controllingInterestsbus:Consolidated2023-03-3108670889core:ShareCapital2021-03-3108670889core:RevaluationReserve2021-03-3108670889core:RetainedEarningsAccumulatedLosses2021-03-3108670889core:RetainedEarningsAccumulatedLosses2022-03-3108670889bus:Consolidated2021-03-31086708892021-03-3108670889core:IntangibleAssetsOtherThanGoodwill2022-04-012023-03-3108670889core:Non-standardIntangibleAssetClass1ComponentIntangibleAssetsOtherThanGoodwill2022-04-012023-03-3108670889core:LandBuildingscore:OwnedOrFreeholdAssets2022-04-012023-03-3108670889core:LandBuildingscore:LongLeaseholdAssets2022-04-012023-03-3108670889core:LeaseholdImprovements2022-04-012023-03-3108670889core:PlantMachinery2022-04-012023-03-3108670889core:FurnitureFittings2022-04-012023-03-3108670889core:MotorVehicles2022-04-012023-03-3108670889core:UKTaxbus:Consolidated2022-04-012023-03-3108670889core:UKTaxbus:Consolidated2021-04-012022-03-3108670889core:Non-standardIntangibleAssetClass1ComponentIntangibleAssetsOtherThanGoodwillbus:Consolidated2022-03-3108670889core:LandBuildingscore:OwnedOrFreeholdAssetsbus:Consolidated2022-03-3108670889core:LandBuildingscore:LeasedAssetsHeldAsLesseebus:Consolidated2022-03-3108670889core:LeaseholdImprovementsbus:Consolidated2022-03-3108670889core:PlantMachinerybus:Consolidated2022-03-3108670889core:FurnitureFittingsbus:Consolidated2022-03-3108670889core:MotorVehiclesbus:Consolidated2022-03-3108670889bus:Consolidated2022-03-3108670889core:LandBuildingscore:OwnedOrFreeholdAssets2022-03-3108670889core:LandBuildingscore:OwnedOrFreeholdAssetsbus:Consolidated2022-04-012023-03-3108670889core:LandBuildingscore:LeasedAssetsHeldAsLesseebus:Consolidated2022-04-012023-03-3108670889core:LeaseholdImprovementsbus:Consolidated2022-04-012023-03-3108670889core:PlantMachinerybus:Consolidated2022-04-012023-03-3108670889core:FurnitureFittingsbus:Consolidated2022-04-012023-03-3108670889core:MotorVehiclesbus:Consolidated2022-04-012023-03-3108670889core:UnlistedNon-exchangeTradedbus:Consolidated2023-03-3108670889core:UnlistedNon-exchangeTradedbus:Consolidated2022-03-3108670889core:UnlistedNon-exchangeTraded2023-03-3108670889core:UnlistedNon-exchangeTraded2022-03-3108670889core:CurrentFinancialInstruments2023-03-3108670889core:CurrentFinancialInstruments2022-03-3108670889core:CurrentFinancialInstrumentsbus:Consolidated2023-03-3108670889core:CurrentFinancialInstrumentsbus:Consolidated2022-03-3108670889core:WithinOneYearbus:Consolidated2023-03-3108670889core:WithinOneYearbus:Consolidated2022-03-3108670889core:CurrentFinancialInstrumentscore:WithinOneYear2023-03-3108670889core:CurrentFinancialInstrumentscore:WithinOneYear2022-03-3108670889core:Non-currentFinancialInstrumentscore:AfterOneYearbus:Consolidated2023-03-3108670889core:Non-currentFinancialInstrumentscore:AfterOneYearbus:Consolidated2022-03-3108670889core:Non-currentFinancialInstrumentscore:AfterOneYear2023-03-3108670889core:Non-currentFinancialInstrumentscore:AfterOneYear2022-03-3108670889core:CurrentFinancialInstrumentscore:WithinOneYearbus:Consolidated2023-03-3108670889core:CurrentFinancialInstrumentscore:WithinOneYearbus:Consolidated2022-03-3108670889core:Non-currentFinancialInstrumentscore:AfterOneYearbus:Consolidated12023-03-3108670889core:Non-currentFinancialInstrumentscore:AfterOneYearbus:Consolidated12022-03-3108670889core:Non-currentFinancialInstrumentscore:AfterOneYear22023-03-3108670889core:Non-currentFinancialInstrumentscore:AfterOneYear22022-03-3108670889bus:PrivateLimitedCompanyLtd2022-04-012023-03-3108670889bus:FRS1022022-04-012023-03-3108670889bus:Audited2022-04-012023-03-3108670889bus:ConsolidatedGroupCompanyAccounts2022-04-012023-03-3108670889bus:FullAccounts2022-04-012023-03-31xbrli:purexbrli:sharesiso4217:GBP